Cardinal Health Inc
Research Cardinal Health Inc (CAH) on Bullrun: valuation model: 40.7% overvalued, market cap USD 55.35B, P/E 32.8, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCAH
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyUSD
- Valuation signal40.7% overvalued
- Market capUSD 55.35B
- P/E32.8
- Dividend yield0.9%
- Financial periodFY2026
- RevenueUSD 254.25B
- Revenue growth14.2%
- Net incomeUSD 1.71B
- Free cash flowUSD 4.53B
- Gross margin3.8%
Valuation Snapshot
Bullrun's latest valuation model marks Cardinal Health Inc as 40.7% overvalued; latest market cap is USD 55.35B; P/E is 32.8; dividend yield is 0.9%.
Peer valuation comparison
Latest P/E is 32.82x versus a Healthcare sector median of 24.61x (33.4% above).
Latest dividend yield is 0.86% versus a Healthcare sector median of 1.84% (53.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 254.25B | USD 1.71B | USD 4.53B | 3.8% | 7.23 | USD 4.86B | USD 8.89B | -USD 2.88B |
| FY2025 | USD 222.58B | USD 1.56B | USD 1.85B | 3.7% | 6.45 | USD 3.87B | USD 8.53B | -USD 2.78B |
| FY2024 | USD 226.83B | USD 852.00M | USD 3.25B | 3.3% | 3.45 | USD 5.13B | USD 5.09B | -USD 3.21B |
| FY2023 | USD 204.98B | USD 330.00M | USD 2.36B | 3.4% | 1.26 | USD 4.08B | USD 4.70B | -USD 2.96B |
| FY2022 | USD 181.33B | -USD 938.00M | USD 2.79B | 3.6% | -3.37 | USD 4.72B | USD 5.32B | -USD 709.00M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 55.35B | 32.8 | 0.9% | 2.05 |
| 2025 | 2025-12-31 | USD 48.41B | 29.6 | 1.0% | 2.04 |
| 2024 | 2024-12-31 | USD 28.62B | 22.0 | 1.3% | 1.52 |
| 2023 | 2023-12-29 | USD 24.84B | 176.8 | 2.5% | 2.5 |
| 2022 | 2022-12-30 | USD 20.15B | n/a | 3.2% | 2.48 |
| 2021 | 2021-12-31 | USD 14.26B | 27.0 | 3.8% | 1.96 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.05 USD, yield 0.9%.
| Year | Dividends/share |
|---|---|
| FY2026 | 1.54 USD |
| FY2025 | 2.02 USD |
| FY2024 | 2 USD |
| FY2023 | 1.98 USD |
| FY2022 | 1.96 USD |
About Cardinal Health Inc
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
ETFs that hold Cardinal Health Inc
Cardinal Health Inc is one of the ten largest holdings of one ETF that investors in Europe can buy:
| ETF | Weight | TER |
|---|---|---|
| BNP Paribas Easy MSCI China A UCITS ETF USD Capitalisation | 9.57% | 0.13% |
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Cardinal Health Inc overvalued or undervalued?
Bullrun's valuation model currently marks Cardinal Health Inc as 40.7% overvalued.
What is Cardinal Health Inc's market cap?
Cardinal Health Inc's market capitalization is USD 55.35B.
What is Cardinal Health Inc's P/E ratio?
Cardinal Health Inc's price-to-earnings (P/E) ratio is 32.8.
Does Cardinal Health Inc pay a dividend?
Cardinal Health Inc has a dividend yield of 0.9%.
What does Cardinal Health Inc do?
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.